NWFAX
Price
$32.57
Change
+$0.31 (+0.96%)
Updated
Jan 17 closing price
Net Assets
1.72B
RWEBX
Price
$62.57
Change
+$0.49 (+0.79%)
Updated
Jan 17 closing price
Net Assets
191.91B
Ad is loading...

NWFAX vs RWEBX

Header iconNWFAX vs RWEBX Comparison
Open Charts NWFAX vs RWEBXBanner chart's image
Nationwide A
Price$32.57
Change+$0.31 (+0.96%)
VolumeN/A
Net Assets1.72B
American Funds Washington Mutual R2E
Price$62.57
Change+$0.49 (+0.79%)
VolumeN/A
Net Assets191.91B
NWFAX vs RWEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWFAX vs. RWEBX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWFAX is a Hold and RWEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 192B vs. NWFAX (1.72B). RWEBX pays higher dividends than NWFAX: RWEBX (1.07) vs NWFAX (0.19). NWFAX was incepted earlier than RWEBX: NWFAX (27 years) vs RWEBX (10 years). NWFAX is a more actively managed with annual turnover of: 72.63 vs. RWEBX (30.00). RWEBX has a lower initial minimum investment than NWFAX: RWEBX (250) vs NWFAX (2000). NWFAX (12.09) and RWEBX (11.50) have marching annual gain over last year. NWFAX return over 5 years is better than : 34.44 vs. RWEBX (31.93).
NWFAXRWEBXNWFAX / RWEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years10 years-
Gain YTD2.1962.30595%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets1.72B192B1%
Annual Yield % from dividends0.191.0718%
Returns for 1 year12.0911.50105%
Returns for 3 years11.549.44122%
Returns for 5 years34.4431.93108%
Returns for 10 years56.2960.4293%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEB13.750.05
+0.36%
Pebblebrook Hotel Trust
AZN66.60-0.31
-0.46%
AstraZeneca PLC
CRT10.28-0.05
-0.48%
Cross Timbers Royalty Trust
ARCT16.79-0.22
-1.29%
Arcturus Therapeutics Holdings
ASND128.13-3.49
-2.65%
Ascendis Pharma A/S